SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TFCP2L1 | hg19_v2_chr2_-_122042770_122042785 | 0.85 | 2.7e-06 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_153538011 Show fit | 10.54 |
ENST00000368707.4
|
S100 calcium binding protein A2 |
|
chr1_-_153538292 Show fit | 10.27 |
ENST00000497140.1
ENST00000368708.3 |
S100 calcium binding protein A2 |
|
chr19_-_46916805 Show fit | 7.03 |
ENST00000307522.3
|
coiled-coil domain containing 8 |
|
chr1_-_207206092 Show fit | 6.82 |
ENST00000359470.5
ENST00000461135.2 |
chromosome 1 open reading frame 116 |
|
chr5_-_141257954 Show fit | 6.12 |
ENST00000456271.1
ENST00000394536.3 ENST00000503492.1 ENST00000287008.3 |
protocadherin 1 |
|
chr17_-_39928106 Show fit | 6.02 |
ENST00000540235.1
|
junction plakoglobin |
|
chr15_+_41136216 Show fit | 5.46 |
ENST00000562057.1
ENST00000344051.4 |
serine peptidase inhibitor, Kunitz type 1 |
|
chr18_+_21529811 Show fit | 5.43 |
ENST00000588004.1
|
laminin, alpha 3 |
|
chr15_+_101417919 Show fit | 4.74 |
ENST00000561338.1
|
aldehyde dehydrogenase 1 family, member A3 |
|
chr14_+_24867992 Show fit | 4.67 |
ENST00000382554.3
|
NYN domain and retroviral integrase containing |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 20.8 | GO:0043542 | endothelial cell migration(GO:0043542) |
0.4 | 11.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 9.8 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 8.2 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
1.2 | 7.2 | GO:0030421 | defecation(GO:0030421) |
1.0 | 7.0 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.1 | 5.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.8 | 5.0 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
1.2 | 4.7 | GO:0060166 | olfactory pit development(GO:0060166) |
0.3 | 4.7 | GO:0015074 | DNA integration(GO:0015074) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 7.0 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
0.9 | 7.0 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 6.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.5 | 5.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 4.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 4.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 3.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 3.3 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 3.2 | GO:0002102 | podosome(GO:0002102) |
0.0 | 2.8 | GO:0030175 | filopodium(GO:0030175) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 21.8 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 11.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 8.2 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
1.8 | 7.0 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
1.1 | 6.8 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 6.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 6.0 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 5.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 5.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 5.0 | GO:0005123 | death receptor binding(GO:0005123) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 14.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 13.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 7.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 7.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 3.7 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 3.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 3.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 2.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 2.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 12.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.2 | 10.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 7.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 6.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 5.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 3.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 3.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 2.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 2.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 2.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |